• Title of article

    Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors

  • Author/Authors

    Dana Ferraris، نويسنده , , Yao-Sen Ko، نويسنده , , David Calvin، نويسنده , , Tiffany Chiou، نويسنده , , Susan Lautar، نويسنده , , Bert Thomas، نويسنده , , Krystyna Wozniak، نويسنده , , Camilo Rojas، نويسنده , , Vincent Kalish، نويسنده , , Sergei Belyakov، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2004
  • Pages
    5
  • From page
    5579
  • To page
    5583
  • Abstract
    In this paper, the synthesis and structure–activity relationships (SAR) of two classes of electrophile-based dipeptidyl peptidase IV (DPP IV) inhibitors, the ketopyrrolidines and ketoazetidines, is discussed. The SAR of these series demonstrate that the 2-thiazole, 2-benzothiazole, and 2-pyridylketones are optimal S1′ binding groups for potency against DPP IV. In addition, both cyclohexyl glycine (CHG) and octahydroindole carboxylate (OIC) serve as the most potent S2 binding groups within each series. Stereochemistry at the α-position of the central ring is relevant to potency within the ketopyrrolidines series, but not in the ketoazetidine series. Finally, the ketoazetidines display enhanced stability over the corresponding ketopyrrolidines, while maintaining their potency. In fact, certain stabilized ketoazetidines can maintain their in vitro potency and inhibit DPP IV in the plasma for up to 6 h.
  • Keywords
    Serine protease.* Corresponding author. Tel.: +1 410 631 8126 , fax: +1 410 6316797 , e-mail: ferrarisd@guilfordpharm.com , DPP IV , Diabetes
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Serial Year
    2004
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Record number

    795028